Colin Reisner
Amministratore Delegato presso Pearl Therapeutics, Inc.
Profilo
Colin Reisner is currently the Chief Executive Officer at Pearl Therapeutics, Inc. and a Member at the American Thoracic Society, Inc. Previously, he held positions as the Executive Director-Global Respiratory Development at Novartis Corp., Senior Director-Respiratory Division at GlaxoSmithKline, Inc., Head-Clinical Respiratory at AstraZeneca PLC, Assistant Consulting Professor at Duke University and Yale University, and Principal at Boehringer Ingelheim Corp.
He completed his undergraduate degree at the University of the Witwatersrand.
Posizioni attive di Colin Reisner
Società | Posizione | Inizio |
---|---|---|
Pearl Therapeutics, Inc.
Pearl Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Pearl Therapeutics, Inc. develops therapies for the treatment of chronic respiratory diseases. It offers respiratory product development, high quality therapies for COPD, Asthma and treatment and prevention of chronic respiratory diseases and asthma. The company was founded in 2006 by Sarvajna Dwivedi and is headquartered in Redwood City, CA. | Amministratore Delegato | 01/10/2007 |
American Thoracic Society, Inc.
American Thoracic Society, Inc. Miscellaneous Commercial ServicesCommercial Services American Thoracic Society, Inc. is a professional membership organization for thoracic surgeons. The non-profit company is based in New York, NY. | Corporate Officer/Principal | - |
Precedenti posizioni note di Colin Reisner
Società | Posizione | Fine |
---|---|---|
ASTRAZENECA PLC | Corporate Officer/Principal | - |
Duke University
Duke University Other Consumer ServicesConsumer Services Duke University is an academic university that offers undergraduate, graduate and professional programs. It also has publications and research services. The university was founded in 1838 and is headquartered in Durham, NC. | Corporate Officer/Principal | - |
Yale University | Corporate Officer/Principal | - |
Boehringer Ingelheim Corp.
Boehringer Ingelheim Corp. Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim Corp. develops, manufactures and markets health care products. It focuses in the therapeutic areas of cardiovascular disease, respiratory diseases, diseases of the central nervous system, metabolic diseases, virological diseases and oncology. The company was founded on December 8, 1986 and is headquartered in Ridgefield, CT. | Corporate Officer/Principal | - |
GlaxoSmithKline, Inc.
GlaxoSmithKline, Inc. Pharmaceuticals: MajorHealth Technology GlaxoSmithKline, Inc. manufactures and markets pharmaceutical products. The company develops medicines to prevent infections that cause serious medical problems such as respiratory illnesses, diabetes, viral control, infections, and central nervous system disorders. The company is headquartered in Mississauga, Canada. | Corporate Officer/Principal | - |
Formazione di Colin Reisner
University of the Witwatersrand | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 1 |
---|---|
ASTRAZENECA PLC | Health Technology |
Aziende private | 5 |
---|---|
Pearl Therapeutics, Inc.
Pearl Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Pearl Therapeutics, Inc. develops therapies for the treatment of chronic respiratory diseases. It offers respiratory product development, high quality therapies for COPD, Asthma and treatment and prevention of chronic respiratory diseases and asthma. The company was founded in 2006 by Sarvajna Dwivedi and is headquartered in Redwood City, CA. | Health Technology |
Novartis Corp.
Novartis Corp. Pharmaceuticals: MajorHealth Technology Novartis Corp. manufactures pharmaceuticals, vaccines, consumer health, generics, eye care and animal health products. It manufactures drugs for oncology, hypertension, diabetes, cancer and cardiovascular diseases. The company was founded on November 15, 1996 and is headquartered in New York, NY. | Health Technology |
GlaxoSmithKline, Inc.
GlaxoSmithKline, Inc. Pharmaceuticals: MajorHealth Technology GlaxoSmithKline, Inc. manufactures and markets pharmaceutical products. The company develops medicines to prevent infections that cause serious medical problems such as respiratory illnesses, diabetes, viral control, infections, and central nervous system disorders. The company is headquartered in Mississauga, Canada. | Health Technology |
Boehringer Ingelheim Corp.
Boehringer Ingelheim Corp. Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim Corp. develops, manufactures and markets health care products. It focuses in the therapeutic areas of cardiovascular disease, respiratory diseases, diseases of the central nervous system, metabolic diseases, virological diseases and oncology. The company was founded on December 8, 1986 and is headquartered in Ridgefield, CT. | Health Technology |
American Thoracic Society, Inc.
American Thoracic Society, Inc. Miscellaneous Commercial ServicesCommercial Services American Thoracic Society, Inc. is a professional membership organization for thoracic surgeons. The non-profit company is based in New York, NY. | Commercial Services |
- Borsa valori
- Insiders
- Colin Reisner